Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

NCT02475733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Intra-abdominal Infections

Interventions

DRUG: Ceftazidime -avibactam
DRUG: Meropenem
DRUG: Metronidazole

Sponsor

Pfizer